MAP4K4 and amyotrophic lateral sclerosis: Previous work indicated that MAP4K4 was among the kinases inhibited by kenpaullone (Yang et al., 2013) and that inhibition of MAP4K4 alone was sufficient to protect against trophic factor withdrawal-induced ALS MN degeneration (Wu et al., 2019).